Publications

Overview 2017 to 2019

Year	Authors	Titel
2019	Gerlza T, Nagele M, Gschwandtner M, Winkler S, Kungl A.	Designing an Improved T-cell Mobilising CXCL10 Mutant Through Enhanced GAG Binding Affinity
2019	Gerlza T, Trojacher C, Jeremic D, Krieger E, Adage T, Kungl A.	PEGylation of a Glycosaminoglycan-Binding, Dominant-Negative CXCL8 Mutant Retains Bioactivity in Vitro and in Vivo
2019	Meyer NH, Dellago H, Tam-Amersdorfer C, et al.	Structural Fuzziness of the RNA-Organizing Protein SERF Determines a Toxic Gain-of-interaction
2019	Eustace AD, McNaughton EF, King S, et al.	Soluble syndecan-3 Binds Chemokines, Reduces Leukocyte Migration in Vitro and Ameliorates Disease Severity in Models of Rheumatoid Arthritis
2019	Merle DA, Witternigg A, Tam-Amersdorfer C, et al.	Increased Aggregation Tendency of Alpha-Synuclein in a Fully Disordered Protein Complex
2018	Winkler S, Derler R, Gesslbauer B, Krieger E, Kungl AJ.	Molecular Dynamics Simulations of the Chemokine CCL2 in Complex With Pull Down-Derived Heparan Sulfate Hexasaccharides
2018	Almer J, Gesslbauer B, Kungl AJ.	Therapeutic strategies to target microbial protein-glycosaminoglycan interactions
2018	Vanheule V, Crijns H, Poosti F, et al.	Anti-inflammatory effects of the GAG-binding CXCL9(74-103) peptide in dinitrofluorobenzene-induced contact hypersensitivity in mice
2018	McNaughton EF, Eustace AD, King S, et al.	Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis
2017	Derler R, Gesslbauer B, Weber C, Strutzmann E, Miller I, Kungl A.	Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells
2017	Vanheule V, Boff D, Mortier A, et al.	CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan Interactions